Physician profile
Sana U Bhatti
NPI 1366444275
$3,335.15
in general payments reported to CMS, 2019-2025
49 companies · $347 in 2025
The $347 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $415 · 2020: $287 · 2021: $893 · 2022: $548 · 2023: $427 · 2024: $418 · 2025: $347.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,193.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,192.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $476.63 | 2021-2024 | Everest Spinal System, N/A, Caspian Spinal System |
| Biogen, INC. | $191.96 | 2019-2022 | |
| Lemaitre Vascular, INC. | $163.41 | 2025 | Anastoclip Gc 8cm (Medium) |
| Acorda Therapeutics, INC | $146.55 | 2019-2022 | |
| Sk Life Science, INC. | $121.29 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $119.69 | 2019-2022 | |
| Boston Scientific Corporation | $112.97 | 2023-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Eisai INC. | $101.80 | 2021-2022 | |
| Acadia Pharmaceuticals INC | $99.76 | 2021-2023 | Nuplazid |
| Lilly USA, LLC | $93.68 | 2019-2023 | Reyvow, Emgality |
| Alexion Pharmaceuticals, INC. | $92.64 | 2020-2021 | |
| Genzyme Corporation | $89.56 | 2019-2022 | |
| Abbott Laboratories | $87.85 | 2021-2025 | Eterna, Infinity |
| Teva Pharmaceuticals USA, INC. | $87.27 | 2019-2021 | |
| Abbvie INC. | $86.96 | 2019-2024 | Duopa, Ubrelvy |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sana Bhatti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.